Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.
Daily peanut exposure can desensitise allergic adults, study suggests
"The findings suggest that the window of opportunity for treating allergies could extend into adulthood, raising the prospect of new treatments for those severely affected."
NHS England first in Europe to roll out take-at-home pill for MS patients
The NHS in England will introduce an immunotherapy pill for multiple sclerosis patients, improving treatment accessibility and reducing hospital visits.